Company Overview and News

 
ConocoPhillips - Why Give It A Miss?

2018-03-27 seekingalpha
Headquartered in Houston Texas, United States, ConocoPhillips (NYSE:COP) is the world’s biggest independent exploration and production company. Although the company’s financial performance has improved in 2017 and its stock price has risen by more than 20% in the second half of 2017, I firmly believe that it’s better to remain away from COP as its fundamentals are heavily dependent on energy prices.
Upvote Downvote

 
BOE / BlackRock Global Opportunity Equity Trust BLACKROCK ENHANCED GLOBAL DIVIDEND TRUST

2018-03-08 sec.gov
BlackRock Enhanced Global Dividend Trust UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-CSR
Upvote Downvote

 
BOE / BlackRock Global Opportunity Equity Trust null

2018-03-01 sec.gov
PAGE 1 000 B000000 12/31/2017 000 C000000 0001320375 000 D000000 N 000 E000000 NF 000 F000000 Y 000 G000000 N 000 H000000 N 000 I000000 6.1 000 J000000 A 001 A000000 BLACKROCK ENHANCED GLOBAL DIVIDEND TRUST 001 B000000 811-21729 001 C000000 8008820052 002 A000000 100 BELLEVUE PARKWAY 002 B000000 WILMINGTON 002 C000000 DE 002 D010000 19809 003 000000 N 004 000000 N 005 000000 N 006 000000 N 007 A000000 N 007 B000000 0 007 C010100 1 008 A000001 BLACKROCK ADVISORS, LLC 008 B0000
Upvote Downvote

 
BOE / BlackRock Global Opportunity Equity Trust - Stock Institutional Ownership and Shareholders - Fintel.io

2018-02-14 fintel.io
BlackRock Global Opportunity Equity Trust (NYSE:BOE) has 88 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 19,795,926 shares. Largest shareholders include Morgan Stanley, 1607 Capital Partners, LLC, Wells Fargo & Company/mn, Invesco Ltd., Parametric Portfolio Associates Llc, UBS Group AG, Guggenheim Capital Llc, Advisors Asset Management, Inc.
Upvote Downvote

 
BOE / BlackRock Global Opportunity Equity Trust / 1607 Capital Partners, LLC - 13G/A (Passive Investment)

2018-02-14 sec.gov
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549   SCHEDULE 13G/A  Under the Securities Exchange Act of 1934 (Amendment No. 2)* BlackRock Enhanced Global Dividend Trust (Name of Issuer)   Closed End Mutual Fund (Title of Class of Securities)   092501105 (CUSIP Number)     December 31, 2017 (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   x Rule 13d-1(b) o Rule 13d-1(c) o Ru
Upvote Downvote

 
BOE / BlackRock Global Opportunity Equity Trust / 1607 Capital Partners, LLC - 13G/A (Passive Investment)

2018-02-14 sec.gov
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549   SCHEDULE 13G/A  Under the Securities Exchange Act of 1934 (Amendment No. 2)* BlackRock Enhanced Global Dividend Trust (Name of Issuer)   Closed End Mutual Fund (Title of Class of Securities)   092501105 (CUSIP Number)     December 31, 2017 (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   x Rule 13d-1(b) o Rule 13d-1(c) o Ru
Upvote Downvote

 
BOE / BlackRock Global Opportunity Equity Trust / MORGAN STANLEY - MS AMENDMENT (Passive Investment)

2018-02-14 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.3)* BlackRock Enhanced Global Dividend Trust ----------------------------------------------------- (Name of Issuer) Common Stock ----------------------------------------------------- (Title of Class of Securities) 092501105 ----------------------------------------------------- (CUSIP Number) December 29, 2017 ------------------------------------------------
Upvote Downvote

 
BOE / BlackRock Global Opportunity Equity Trust / MORGAN STANLEY - MS AMENDMENT (Passive Investment)

2018-02-14 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.3)* BlackRock Enhanced Global Dividend Trust ----------------------------------------------------- (Name of Issuer) Common Stock ----------------------------------------------------- (Title of Class of Securities) 092501105 ----------------------------------------------------- (CUSIP Number) December 29, 2017 ------------------------------------------------
Upvote Downvote

1
Sword Of Damocles: Unintended Consequences Of Federal Tax Reform And Monetary Policy

2018-01-02 seekingalpha
The big economic events that just took place were the passage of the Trump tax cut, the rate hike of 0.25% by the Fed with projections to make three more next year, and the ramping up of balance sheet reduction at the Fed. All will have either a dramatic new impact or will add dramatically to prior actions. On the one hand, we have added liquidity into our economy, and on the other hand we have reduced liquidity.
Upvote Downvote

 
Blackrock Enhanced Global Dividend Trust - BLACKROCK ENHANCED GLOBAL DIVIDEND TRUST

2017-11-22 sec.gov
BlackRock Enhanced Global Dividend Trust UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number: 811-21729 Name of Fund: BlackRock Enhanced Global Dividend Trust (Formerly BlackRock Global Opportunities             Equity Trust) (BOE) Fund Address: 100 Bellevue Parkway, Wilmington, DE 19809 Name and address of agent for service: John M.
Upvote Downvote

 
Understanding Financial Instability: 'Show Me The Money! (I Mean Credit),' Part I

2017-11-21 seekingalpha
Mainstream macroeconomics gets so many things wrong, especially when it comes to credit and money -- we begin by setting the record straight.
Upvote Downvote

 
BlackRock Global Opportunity Equity Trust MS AMENDMENT (Passive Acquisition of More Than 5% of Shares)

2017-10-10 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.2)* BlackRock Enhanced Global Dividend Trust ----------------------------------------------------- (Name of Issuer) Common Stock ----------------------------------------------------- (Title of Class of Securities) 092501105 ----------------------------------------------------- (CUSIP Number) September 29, 2017 -----------------------------------------------
Upvote Downvote

 
BlackRock Global Opportunity Equity Trust MS AMENDMENT (Passive Acquisition of More Than 5% of Shares)

2017-10-10 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.2)* BlackRock Enhanced Global Dividend Trust ----------------------------------------------------- (Name of Issuer) Common Stock ----------------------------------------------------- (Title of Class of Securities) 092501105 ----------------------------------------------------- (CUSIP Number) September 29, 2017 -----------------------------------------------
Upvote Downvote

 
BlackRock Global Opportunity Equity Trust BLACKROCK ENHANCED GLOBAL DIVIDEND TRUST

2017-09-05 sec.gov
BlackRock Enhanced Global Dividend Trust UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-CSR CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT INVESTMENT COMPANIES Investment Company Act file number: 811-21729 Name of Fund: BlackRock Enhanced Global Dividend Trust (Formerly BlackRock Global Opportunities Equity Trust) (BOE) Fund Address: 100 Bellevue Parkway, Wilmington, DE 19809 Name and address of agent for service: John M.
Upvote Downvote

 
BlackRock Global Opportunity Equity Trust 9.77Q1 OTHR EXHB

2017-08-28 sec.gov
BlackRock Enhanced Global Dividend Trust File No. 811-21729 Sub-Item No. 77Q1(a): Copies of material amendments to Registrant's charter or by-laws Attached please find as an exhibit under Sub-Item 77Q1(a) of Form N-SAR, a copy of the Registrant's Certificate of Amendment to the Registrant's Certificate of Trust relating to the Registrant's name change on June 12, 2017 and filed with the Secretary of the State of Delaware.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 092501105